Levodopa CAS#59-92-7
Levodopa, also known as L-DOPA or 3,4-dihydroxy-L-phenylalanine, is a naturally occurring amino acid and a critical precursor in the biosynthesis of the neurotransmitters dopamine, norepinephrine, and epinephrine. With the molecular formula C9H11NO4, levodopa is a large, neutral amino acid that plays a significant role in the treatment of Parkinson’s disease due to its ability to cross the blood-brain barrier and be converted into dopamine.
Chemically, levodopa is synthesized from the precursor amino acid tyrosine through the action of the enzyme tyrosine hydroxylase. As a medication, levodopa is often formulated with a peripheral DOPA decarboxylase inhibitor to reduce its conversion to dopamine outside the brain, thereby increasing its effectiveness and reducing side effects.
Levodopa is characterized by its effectiveness in alleviating the motor symptoms of Parkinson’s disease, such as tremors, rigidity, and bradykinesia. It is typically administered orally and absorbed from the gastrointestinal tract, where it is then transported to the brain.
In summary, levodopa is a vital pharmaceutical compound used in neurology for its role in treating Parkinson’s disease by replenishing the brain’s dopamine levels. Its targeted delivery and conversion to dopamine make it an essential treatment option for managing the motor symptoms associated with this condition.
| Levodopa Chemical Properties |
| Melting point | 276-278 ??C (lit.) |
| Boiling point | 334.28??C (rough estimate) |
| alpha | -11.7 o (c=5.3, 1N HCl) |
| density | 1.3075 (rough estimate) |
| refractive index | -12 ?? (C=5, 1mol/L HCl) |
| storage temp. | 2-8??C |
| solubility | Slightly soluble in water, practically insoluble in ethanol (96 per cent). It is freely soluble in 1 M hydrochloric acid and sparingly soluble in 0.1 M hydrochloric acid . |
| pka | 2.32(at 25??) |
| form | Crystalline Powder |
| color | White to creamy |
| Odor | at 100.00 %. odorless |
| Odor Type | odorless |
| Water Solubility | Slightly soluble in water, dilute hydrochloric acid and formic acid. Insoluble in ethanol. |
| Merck | 14,5464 |
| BRN | 2215169 |
| Stability: | Stable. Incompatible with strong oxidizing agents. Light and air sensitive. |
| InChIKey | WTDRDQBEARUVNC-LURJTMIESA-N |
| LogP | -1.154 (est) |
| CAS DataBase Reference | 59-92-7(CAS DataBase Reference) |
| NIST Chemistry Reference | Levodopa(59-92-7) |
| EPA Substance Registry System | Levodopa (59-92-7) |
| Safety Information |
| Hazard Codes | Xn |
| Risk Statements | 22-36/37/38-20/21/22 |
| Safety Statements | 26-36-24/25 |
| WGK Germany | 3 |
| RTECS | AY5600000 |
| F | 10-23 |
| TSCA | Yes |
| HS Code | 29225090 |
| Hazardous Substances Data | 59-92-7(Hazardous Substances Data) |
| Toxicity | LD50 in mice (mg/kg): 3650 ??327 orally, 1140 ??66 i.p., 450 ??42 i.v., >400 s.c.; in male, female rats (mg/kg): >3000, >3000 orally; 624, 663 i.p.; >1500, >1500 s.c. (Clark) |
Related Products
Product name:HYDROXYPROPYL GUAR HYDROXYPROPYLTRIMONIUM CHLORIDE
Purity:99%
Appearance:Light Yellow Powder
Package:Customized according to customer needs.
Sample:Available
Urapidil is a sympathetic antihypertensive drug. It acts as ?? 1 ?C adrenoceptor antagonists and 5-HT 1A receptor agonists act. Although the initial report showed that urapidil was also a ?? 2 ?C adrenoceptor agonist, which was not confirmed in later studies, proved that it had no agonist effect in the saphenous vein of dogs and ileum of guinea pigs. With others ?? Unlike 1-adrenoceptor villains, urapidil does not cause response tachycardia, which may be connected to its weak ?? 1-adrenoceptor antagonist activity and its impact on heart vagal drive. Urapidil has actually not been approved by the US Food and drug administration, yet it is offered in Europe.
Urapidil (URA), chemical name is 6-[[3-[4-(2-methoxyphenyl)-1-piperazinyl]propyl]amino]-1,3-dimethyl -2,4(1H,3H)-pyrimidinedione, trade name: ebrantil (ebrantil), synonym: excellent matchi, uracil substituted by phenazine.
Chemical Name: Imazalil Sulfate
CAS No.: 58594-72-2
Molecular Formula: C14H14Cl2N2O.H2SO4
Molecular Weight: 395.26
Appearance: Solid
Chemical Name: Tylosin tartrate
CAS No.:?74610-55-2
Appearance:?white powder
Assay????98.0%
Chemical Name: Marbofloxacin
CAS No.: 115550-35-1
Molecular Formula: C17H19FN4O4
Molecular Weight: 362.36
Appearance: Red-Brown Crystal
Chemical Name: Clindamycin Hydrochloride
CAS No.: 21462-39-5
Molecular Formula: C18H34Cl2N2O5S
Molecular Weight: 461.44
Appearance: White powder
Chemical Name: Zinc citrate
Synonyms: Zinc citrate trihydrate
CAS No.: 546-46-3
Molecular Formula: C6H8O7Zn
Molecular Weight: 257.5
Appearance: White powder
Chemical Name: 3-Hydroxybutyric acid
CAS No.: 625-71-8
Molecular Formula: C4H8O3
Molecular Weight: 104.1
Appearance: White powder
Lidocaine hydrochloride is an anesthetic as well as an antiarrhythmic drug. Clinically, it is mainly used for infiltration anesthetic, epidural anesthetic, topical anesthesia (consisting of mucosal anesthetic throughout thoracoscopic examination or abdominal surgical treatment) as well as nerve conduction block. It can additionally be used for early ventricular tightenings and also ventricular tachycardia after acute myocardial infarction, and also for ventricular arrhythmias triggered by digitalis poisoning, cardiac surgery as well as cardiac catheterization. But it is usually inadequate for supraventricular arrhythmias.
Chemical Name: Trelagliptin succinate
CAS No.: 1029877-94-8
Molecular Fomula: C22H26FN5O6
Molecular weight: 475.48
Appearance: White powder
Assay: ??99.0%
Chemical Name: STODDARD SOLVENT
CAS No.: 64742-88-7
Appearance: Colorless or Light Yellow Liquid
Chemical Name: Sultamicillin
CAS No.: 76497-13-7
Appearance:?White powder
Assay??99.0%
